Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02720250
Other study ID # 2158610714114
Secondary ID
Status Recruiting
Phase N/A
First received March 22, 2016
Last updated March 29, 2016
Start date March 2016
Est. completion date December 2018

Study information

Verified date March 2016
Source Josip Juraj Strossmayer University of Osijek
Contact Ana Stupin, MD, PhD
Phone +385915134958
Email anacavka@mefos.hr
Is FDA regulated No
Health authority Croatia: Ministry of Science, Education and Sports
Study type Interventional

Clinical Trial Summary

Previous studies have shown that omega-3 fatty acid pills intake have beneficial effect on vascular health in overweight and/or hypertensive patients.

However, there is a lack of studies showing the effect of everyday consumption of omega-3 fatty acids enriched food (not pills) on lipid profile and microvascular reactivity in healthy population.

This study aimed to determine the effect of omega-3 enriched chicken eggs consumption on microvascular reactivity and lipid profile in young healthy subjects.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 2018
Est. primary completion date December 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- healthy volunteers

Exclusion Criteria:

- oral contraceptives

- drugs that could affect endothelium

- hypertension

- coronary artery disease

- diabetes

- hyperlipidaemia

- renal impairment

- cerebrovascular and peripheral artery disease

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)


Related Conditions & MeSH terms

  • Omega-3 Polyunsaturated Fatty Acids

Intervention

Dietary Supplement:
Omega-3 chicken eggs
Intake of 3 omega-3 fatty acids enriched chicken eggs per day for three weeks.
Regular chicken eggs
Intake of 3 regular chicken eggs per day for three weeks.

Locations

Country Name City State
Croatia Faculty of Medicine Osijek, Laboratory for Clinical and Sport Physiology Osijek

Sponsors (1)

Lead Sponsor Collaborator
Josip Juraj Strossmayer University of Osijek

Country where clinical trial is conducted

Croatia, 

References & Publications (1)

Cavka A, Cosic A, Jukic I, Jelakovic B, Lombard JH, Phillips SA, Seric V, Mihaljevic I, Drenjancevic I. The role of cyclo-oxygenase-1 in high-salt diet-induced microvascular dysfunction in humans. J Physiol. 2015 Dec 15;593(24):5313-24. doi: 10.1113/JP271631. Epub 2015 Dec 7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary microvascular reactivity Cutaneous microvascular blood flow will be measured by Laser Doppler Flowmetry in response to vascular occlusion (post occlusive reactive hyperaemia - PORH) and in response to iontophoresis of acetylcholine (ACh) (endothelium dependent vasodilation). Three weeks No
Secondary lipid profile Measurement of plasma cholesterol, HDL cholesterol, LDL cholesterol and triglycerides level. Three weeks No
See also
  Status Clinical Trial Phase
Completed NCT04572789 - Omega-3 Fatty Acid in the Prevention of Migraine N/A